|
|
PVCT Provectus Biopharmaceuticals
|
|
||
Hmmmmm....BMY is w/o a Psoriasis drug (FTC made them divest Otezla when they acquired CELG)Meanwhile.....PH-10 is being positioned to start a P3! I would think that a BP that is searching for a potential Psoriasis drug might want to read Dr Kreuger's patent app! Dom could you send a copy of the Patent App over to BMY? |
return to message board, top of board |